Takara Bio USA Holdings, Inc. (“TBUSH”) announces the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics. This strategic acquisition combines two innovative spatial biology platforms with Takara Bio’s industry-leading portfolio of single-cell genomics tools. Curio Bioscience is advancing a new generation of high-precision tools for the life sciences industry. The company has developed innovative spatial biology capabilities to map the whole transcriptome at high resolution using existing sequencing workflows and instrumentation.
Read the full article: Takara Bio USA Holdings, Inc. Announces the Acquisition of Curio Bioscience, Adding Spatial Biology to Its Broad Portfolio of Single-Cell Omics Solutions //
Source: https://www.businesswire.com/news/home/20250114931952/en/Takara-Bio-USA-Holdings-Inc.-Announces-the-Acquisition-of-Curio-Bioscience-Adding-Spatial-Biology-to-Its-Broad-Portfolio-of-Single-Cell-Omics-Solutions